Equity Research · Friday, September 4, 2026
PATH Stock Analysis for September 2026
UiPath, Inc.
Price at Analysis
1Y Price Target
$18.50
+1.5%
vs current price
Technical Setup
RSI 71 / bullish (price in strong uptrend, but momentum stretched/overbought) MACD
Support context: $9.20. Resistance context: $19.84.
Valuation Snapshot
P/E ~16.5x forward P/E; TTM P/E elevated given GAAP profitability just achieved / P/S ~3.85x TTM P/S
Market cap $9.44B; revenue $1.6B FY2026 (+13%); Q1 FY2027 $418M (+17%); FY2027 guide ~$1.8B (~10%).
Risk Watch
AI commoditization of RPA
LLM-native agents could erode the core RPA franchise that still funds the P&L. Even bulls acknowledge the hybrid model's unit economics for enterprise clients remain uncertain. This is the reason the stock trades at a persistent discount.
01 · Summary
Executive Summary
UiPath has staged a dramatic recovery — the stock is up ~98% from its 52-week low of $9.20 and now sits within 8% of its 52-week high. The turnaround narrative is legitimate: 17% Q1 FY2027 revenue growth, first-ever GAAP profitability, 22% non-GAAP operating margin, $1.9B ARR (+12%), 109% net retention, $1.3B net cash, and $500M buyback. The market has already noticed — the stock rallied ~44% in three months and 40% in the month before Q2 earnings. The problem is that at $18.22, the easy money has been made. The stock now trades at roughly 16-18x forward earnings and ~3.9x P/S — no longer distressed. Q2 merely met EPS estimates with modest ~10% full-year growth guidance, the stock turned lower after hours on the print, and Q2's EPS is guided flat YoY at $0.15. RSI at 70.9 signals overbought conditions after a nearly 70% run. Even bulls concede monetization of Maestro/agentic AI is unproven while AI-disruption fear lingers. A 25% short interest provided squeeze fuel that has largely been spent. My prior neutral call ($11.50 1Y target from $10.69) was validated on direction but too conservative — the fundamental inflection (GAAP profitability, accelerated Q1 growth) was stronger than I credited. Now, however, I see a balanced risk/reward at $18.22: continued margin expansion and buybacks support a drift higher over three years, but decelerating headline growth (~10% FY guidance) and AI commoditization risk cap near-term upside. Verdict: neutral, with 1Y target $18.50 and 3Y target $22.
02 · Scenario Modeling
Price Targets
$18.50+1.5%
$22.00+20.7%
1-Year scenario price targets · Dashed line = current price
02 · Scenario Modeling
Scenario Analysis
| Scenario | 1Y Target | 1Y Growth | 3Y Target | 3Y Growth |
|---|---|---|---|---|
↑↑Hyper Bull | $28.00 | +53.7% | $42.00 | +130.5% |
↑Bull | $22.00 | +20.7% | $28.00 | +53.7% |
→Neutral | $18.50 | +1.5% | $22.00 | +20.7% |
↓Bear | $14.50 | -20.4% | $13.00 | -28.6% |
↓↓Hyper Bear | $10.00 | -45.1% | $7.00 | -61.6% |
03 · Fundamentals
Key Financial Metrics
- Earnings Per Share (EPS)
- $0.15 Q2 FY2027 (flat YoY)
- Beta
- ~1.5 (est., high-volatility software)
- Revenue
- $1.6B FY2026 (+13%); Q1 FY2027 $418M (+17%); FY2027 guide ~$1.8B (~10%)
- P/E Ratio
- ~16.5x forward P/E; TTM P/E elevated given GAAP profitability just achieved
- P/S Ratio
- ~3.85x TTM P/S
- Market Cap
- $9.44B
- Net Income
- $282.3M FY2026 (17.5% net margin); first Q1 GAAP profit in Q1 FY2027
- Dividend Yield
- 0%
- Short Interest
- ~25% of float (elevated; squeeze fuel largely spent after 98% rally)
- 52-Week Low
- $9.20
- 52-Week High
- $19.84
02 · Scenario Modeling
Technical Overview
Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.
RSI (14)
70.9
Momentum Stack
1M +31.8% / 3M +56.1%
Volatility Regime
56.7% 20D vol
Regression Fit
+51.2% vs trend
Drawdown Curve
Distance from rolling peak, useful for regime stress and recovery speed.
-5.5%
Trend Regime
bullish
Price > 50D > 200D
Composite Signal
bullish
Bullish (+3)
Mean Reversion
neutral
+1.37 sigma
Breakout Status
neutral
Inside channel
Range Percentile
bullish
85th pct
Volume Impulse
neutral
0.95x 20D avg
Quant Dashboard
A compact read on trend persistence, stretch, realized risk, and breakout behavior.
- 1M Return
- +31.8%
- 6M Return
- +57.7%
- 1Y Return
- N/A
- ATR (14)
- $0.76
- 20D Vol
- 56.7%
- 60D Vol
- 56.1%
- Regression R²
- 0.06
- Price Z-Score
- +1.37
- 52W High
- $19.84
- 52W Low
- $9.20
- Range Position
- 85th pct
- Latest Volume
- 62.7M
04 · Research
Micro Analysis
UiPath's fundamentals have inflected positively: Q1 FY2027 revenue grew 17% to $418M, ARR reached $1.9B (+12.2%), non-GAAP operating margin hit 22%, and the company achieved its first-ever Q1 GAAP profitability. Full-year FY2026 net income was $282M (17.5% net margin) with $352M in free cash flow. The balance sheet is strong with $1.3B cash, no debt, a 2.5x current ratio, and an active $500M buyback. Net retention ticked up to 109% from 108%, and AI products contribute ~$200M ARR. However, Q2 FY2027 merely met EPS estimates ($0.15, flat YoY), full-year guidance implies only ~10% growth, and the stock turned lower after earnings — the market wanted more. The Maestro agentic AI orchestration platform is the growth catalyst, but its monetization remains unproven against Microsoft and native AI-agent competitors.
Fundamental inflection is real
Q1 FY2027 revenue +17% to $418M, first Q1 GAAP profitability, 22% non-GAAP operating margin, ARR +12.2% to $1.9B, NRR improved to 109%. FY2026 delivered $282M net income (17.5% margin) and $352M FCF.
Growth is decelerating again
Despite the strong Q1, full-year FY2027 guidance implies only ~10% revenue growth, and Q2 EPS is flat YoY at $0.15. Zacks rates it Hold with no estimate revisions in 30 days — expectations are stagnant.
Valuation no longer distressed
At ~16.5x forward P/E and ~3.85x TTM P/S, PATH has re-rated from the 14x trough. It's still a discount to sector medians, but the deep-value margin of safety is largely gone after a 98% rally off the low.
Balance sheet and buybacks
$1.3B cash, zero debt, 2.5x current ratio, and a $500M buyback program provide downside support and EPS accretion that bears underweight.
Agentic AI: opportunity and threat
Maestro orchestration and the WorkFusion acquisition position UiPath for agentic automation, but AI product ARR (~$200M) hasn't yet offset fears that LLM-native agents commoditize classic RPA. Term licensing model avoids token-cost exposure — a genuine structural advantage.
04 · Research
Macro Analysis
Enterprise software sentiment has rotated sharply — from fears that AI would kill SaaS business models earlier in 2026, to a renewed rally in the peer group (PATH gained ~12% in one week on sector momentum alone). Agentic AI is the dominant theme, with capital rotating into orchestration/automation names. Rates remain a tailwind for profitable, cash-generative software. However, the sector is volatile and crowded, and PATH's recent gains owe as much to sector beta as to fundamentals.
Sector sentiment rotation
Enterprise software rallied broadly in recent weeks; PATH's 12% weekly gain came with no company-specific news, showing how much of the move is sector-driven and reversible.
Agentic AI investment cycle
Enterprises are piloting AI-agent deployments; orchestration platforms like Maestro are direct beneficiaries, but the monetization timeline across the industry is unproven.
Competitive intensity
Microsoft (Power Automate/Copilot), ServiceNow, and native AI-agent startups all target the same automation budget. UiPath's deterministic orchestration + computer vision is differentiated but not unassailable.
Macro tailwind for automation
Enterprises under persistent cost pressure continue funding automation ROI projects; claims processing, invoice-to-cash, and onboarding remain durable use cases across Americas/EMEA/APAC.
05 · Growth
Untapped Revenue Opportunities
Maestro agentic AI orchestration
highPositioning UiPath as the deterministic control plane for AI agents in the enterprise. AI products already contribute ~$200M ARR; successful Maestro monetization could re-accelerate ARR growth from 12% toward mid-teens and drive multiple re-rating.
Margin expansion + buybacks compounding EPS
high22% non-GAAP operating margin has room to expand toward 25%+; $500M buyback (plus possible renewals) shrinks share count while FCF of $350M+ continues. EPS can grow ~20% annually even on ~10% revenue growth.
Net retention improvement
mediumNRR at 109% is up from 108% but still modest. Rising large-customer counts, the WorkFusion acquisition, and forward-deployed engineering could push NRR toward 112-115%, adding meaningful ARR on the $1.9B base.
RPO/backlog acceleration
medium06 · Catalysts
Headwinds & Tailwinds
↓ Headwinds
AI commoditization of RPA
highLLM-native agents could erode the core RPA franchise that still funds the P&L. Even bulls acknowledge the hybrid model's unit economics for enterprise clients remain uncertain. This is the reason the stock trades at a persistent discount.
Decelerating guided growth
highFY2027 guidance implies only ~10% top-line growth, and Q2 EPS is flat YoY. With RSI at 70.9 and the stock up ~70% in months, any guidance disappointment has asymmetric downside.
Overbought technicals / spent squeeze fuel
mediumRSI 70.9, price within 8% of the 52-week high, and a 40% one-month rally into the Q2 print. The 25% short interest that powered the squeeze has largely covered; the marginal buyer must now be a fundamentals buyer.
Stagnant consensus estimates
mediumNo EPS revisions in 30 days and a Zacks #3 Hold — the analyst community sees no upward earnings momentum to justify further multiple expansion near-term.
↑ Tailwinds
First-ever sustained GAAP profitability
highFY2026 net income of $282M (17.5% net margin) and Q1 FY2027 GAAP profit mark a structural shift from cash-burning growth to self-funding compounding, broadening the shareholder base.
Fortress balance sheet
high$1.3B cash, zero debt, 2.5x current ratio, $352M FCF — funds buybacks, M&A (WorkFusion), and weathering any AI-transition turbulence.
Term licensing model avoids AI token economics
mediumPer-seat/term licensing provides predictable revenue while pure-token AI vendors face unpredictable inference costs — a structural moat as agentic workloads scale.
Accelerating backlog (RPO +17%)
mediumRPO growth outpacing revenue growth signals demand strength and gives visibility that guided deceleration may prove conservative.
Sector rotation into agentic AI names
mediumEnterprise software is back in favor; PATH's peer-driven rallies show sentiment can add several points of multiple even without news.
07 · TL;DR
Analysis Summary
- Ticker
- PATH
- Company
- UiPath, Inc.
- Analysis Date
- 2026-09-04
- Price at Analysis
- $18.22
- Rating
- Hold
- 1Y Price Target
- $18.50
- 3Y Price Target
- $22.00
- Market Cap
- $9.44B
- P/E Ratio
- ~16.5x forward P/E; TTM P/E elevated given GAAP profitability just achieved
This analysis was generated on 2026-09-04 when PATH was trading at $18.22. The base-case 1-year price target is $18.50 (+1.5% implied return). Scenario range: $10.00 (hyper bear) to $28.00 (hyper bull).